ArticleMetabolites2026

Differential Modulation of Serum Albumin and Butyrylcholinesterase Following Pemafibrate Treatment in MASLD: A Post Hoc Analysis of the PEMA-FL Trial.

Ryohei Tanigawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.